A Comparison of Transvenous Atrial Defibrillation of Acute and Chronic Atrial Fibrillation and the Effect of Intravenous Sotalol on Human Atrial Defibrillation Threshold

The comparative efficacy and safety of transvenous defibrillation for acute and chronic AF and the effect of antiarrhythmic agents on this therapy have not been evaluated. Transvenous atrial defibrillation was performed in 25 patients with chronic AF and 13 patients with acute AF by delivering R wave synchronized, biphasic shocks between the right atrium and coronary sinus. The lowest energy and voltage resulting in successful defibrillation were considered to be atrial defibrillation threshold (ADFT). Intravenous sotalol (1.5 mg/kg) was thengiven over 15 minutes and ADFT was determined again. The mean ADFT was 1.5 /and 3.6 J for acute and chronic AF, respectively, and the threshold was highly reproducible. Sotaloi reduced ADFT in patients with acute AF while the reduction in chronic AF group was not significant. There was no significant increase in creatinine kinase nor reduction in blood pressure, but prolonged pause after successful defibrillation required ventricular supporting pacing. We conclude that transvenous atrial defibrillation is a safe and effective means for defibrillating both acute and chronic AF. ADFT was lower in acute AF than in chronic AF. ADFT was highly reproducible during repeated defibrillation. Sotalol reduced ADFT in acute AF and to a lesser extent in chronic AF, and increased the defibrillation success rate. Ventricular pacing will often be required because of prolonged pause after successful defibrillation.     

Transvenous Single Lead Atrial Defibrillation: Efficacy and Risk of Ventricular Fibrillation in an Ischemic Canine Model

Transvenous atrial defibrillation with multiple atrial lead systems has been shown to be effective in models without the potential for ventricular arrhythmias. The specific aim of this study was to evaluate the efficacy and safety of transvenous single lead atrial defibrillation in a canine model of ischemia cardiomyopathy. Ten dogs had ischemia cardiomyopathy induced by repeated intracoronary micmsphere injections. The mean LV ejection fraction decreased from 71%± 9% to 38%± 14% (P = 0.003). Spontaneous atrial fibrillation (AF) developed in four dogs, and in six AF was induced electrically. Atrial defibrillation thresholds (ADFTs) were determined with synchronous low energy shocks using a transvenous tripolar lead with two defibrillation coils (right ventricle, superior vena cava) and an integrated sensing lead (RV coil vs electrode tip). The ADFTs derived by logistic regression were compared at 50% and 90% probability of success (ED₅₀, ED₉₀): ED₅₀ was 2.4 ±1.7 J and 2.9 ±2.1 J, respectively, for 5- and 10-ms monophasic shocks, and 1.8 ± 0.9 J and 2.1 ± 1.3 J, respectively, for 5- and 10-ms biphasic shocks. Immediately after 3 of 2,179 (0.1%) synchronized shocks, ventricular fibrillation (VF) developed. VF was induced in 3 of 1,062 (0.3%) shocks with integrated sensing (RV coil vs electrode tip) compared to 0 of 1,117 shocks when a separate bipolar RV sensing electrode was used for synchronization. In our canine model of ischemic cardiomyopathy, low energy atrial defibrillation via a transvenous single lead system was highly effective. However, there was a small but definite risk of VF induction, which seemed to be greater when an integrated as opposed to a true bipolar RV sensing was used.     

Hemodynamic Effects and Clinical Determinants of Defibrillation Threshold for Transvenous Atrial Defibrillation Using Biatrial Biphasic Shocks in Patients with Chronic Atrial Fibrillation

We assessed the relationship between the hemodynamic changes and shock intensity in transvenous atrial defibrillation for chronic AF. The correlation between the clinical profile and atrial DFT and the factors predicting maintenance of SR after successful defibrillation were also investigated. Atrial defibrillation using entirely transvenoas leads has been investigated as an alternative means of managing patients with AF. However, the hemodynamic consequence of this technique and the clinical factors predicting defibrillation efficacy have not been evaluated. Thirty-seven patients with chronic AF (4 weeks to 60 months) underwent transvenoas atrial defibrillation. Defibrillation was performed by delivering R wave synchronized, biphasic (3/3 ms) shocks with step-up voltages (20–400 V) between defibrillation catheters in the anterolateral right atrium and the distal coronary sinus. Clinical profile of the patients, the DFT, arterial blood pressure, and RH interval during defibrillation and the 6-month recurrence rate were determined. SR was restored in 33 (89%) of 37 patients and the DFT was 3.7 ± 1.4 J (317 ± 58 V). Transvenous atrial defibrillation resulted in a mild reduction in blood pressure (6 ± 10 mmHg), but substantial prolongation of longest postshock RR intervals (507 ± 546 ms), which were significantly related to the shock intensity (r = 0.5, P < 0.001). There was no ventricular proarrhythmia. The patients'age, body weight, duration of AF, left atrial diameter, and ejection fraction were not related to the success of defibrillation, not the 6-month maintenance rate of SR (39%). However, the patients'age was related to DFT. Apart from transient reduction in blood pressure and shock related pauses that may require backup pacing, transvenous biatrial defibrillation was a highly effective and well-tolerated technique. The absence of clinical determinant for successful defibrillation suggests that restoring SR by transvenous atrial defibrillation could be attempted in most patients with chronic AF.     

Internal Atrial Defibrillation During Electrophysiological Studies and Focal Atrial Fibrillation Ablation Procedures

Induction of sustained AF during electrophysiological studies requires electrical cardioversion to restore sinus rhythm for continuation of the electrophysiological study and mapping procedure. The study included 104 consecutive patients (age 59 +/- 12 years, 74 men), who were in stable sinus rhythm at the beginning of the electrophysiological study, underwent internal atrial defibrillation (IAD) of AF (> 15 minutes) that was induced during electrophysiological study. In 21 patients, AF was regarded to be the clinical problem (group I), and in the remaining 83 patients other arrhythmias represented the primary target of the electrophysiological study (group II). A 7.5 Fr cardioversion catheter (EP Medical) equipped with a distal array was used and placed in the left pulmonary artery and a proximal array of the same size was located along the lateral right atrial wall. All patients were successfully cardioverted with a mean energy of 6.2 +/- 4.0 1. In 18 (78%) of 21 group I patients and in 12 (14%) of 81 group II patients, AF recurred 3.7 +/- 3.4 and 2.4 +/- 1.4 times during electrophysiological study, respectively. The IAD shock did not suppress focal activity, thus the mapping of atrial foci responsible for AF could be continued even after several IADs. No IAD related complications occurred during the study. In conclusion, (1) IAD can be safely and successfully performed during electrophysiological study without using narcotic drugs or high electric energies; (2) IAD does not suppress focal activity; and (3) even if AF recurs frequently during the electrophysiological study, IAD can be performed several times without significant time delay.     

Rounded Biphasic Waveform Reduces Energy Requirements for Transvenous Catheter Cardioversion of Atrial Fibrillation and Flutter

We postulated that reducing peak leading edge shock voltage and its rate of rise (waveform rounding) would reduce energy requirements for cardioversion of AF and AFI, and may therefore reduce patient discomfort. Transvenous defibrillating catheters (In-Control Inc.) were placed in the RAA (active fixation) and the CS of six anesthetized sheep. AF or AFI was induced by electrical stimulation (100 Hz, 2 V; Grass stimulator). A standard trapezoidal biphasic (S) waveform (3-ms duration each phase) was compared with a similar waveform that had the first phase rounded (R). Cardioversion was attempted after 30 seconds of arrhythmia, using a Ventritex HVS-O₂ defibrillator modified to allow waveform rounding. Each waveform was randomly tested several times at 100-, 150-, and 200-V leading edges, and percentage cardioversion success calculated. Shock energy was calculated from delivered current and voltage using Flukeview (Fluke, Inc.) software. At 100-V leading edge R (64% success) and S (59%), shocks were similarly efficacious (P = 0.37). However. R delivered less current, voltage, and energy than the comparable S shock (means 1.30 A, 65.0 V, 0.33 J R vs 1.92 A, 94.2 V, 0.47 J S; P = 0.0001). Both waveforms were equally successful at 150 V (88% vs 100%; P = NS) and 200 V(100% vs 100%), but again R delivered less current, voltage, and energy (2.05 A, 102.5 V, 0.82 J R vs 2.78 A, 142.3 V, 1.11 J S at 150 V; 2.76 A, 141.2 V, 1.58 J R vs 3.77 A, 189.4 V, 2.03 J S at 200 V; both P = 0.0001). No arrhythmic or other complications occurred in the 174 shocks delivered. Waveform rounding reduces delivered peak voltage, current, and energy without reducing defibrillation efficacy. To determine if these changes are associated with a reduction in discomfort, patients with AF are currently being cardioverted with these waveforms during electrophysiological studies.     

Significant Reduction of Atrial Defibrillation Threshold and Inducibility by Catheter Ablation of Atrial Fibrillation

Background: Radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) has antiarrhythmic effects by multiple mechanisms. We hypothesized that RFCA curtails atrial defibrillation threshold (A‐DFT) and postablation induction pacing cycle length (iPCL), making critical mass reduction one potential mechanism by which antiarrhythmic effect is achieved. Methods: We included 289 patients with AF (male 77.9%, 55.7 ± 10.8 years old; 197 paroxysmal AF: 92 persistent AF) who underwent RFCA. A‐DFT (serial internal cardioversion 2, 3, 5, 7, and 10 J) and iPCL (serial 10 mA 10‐second atrial pacing with pacing cycle length 250, 200, 190, 180, 170, 160, and 150 ms) were evaluated before and after RFCA. Results: (1) RFCA of AF reduced the A‐DFT from 6.7 ± 3.7 J to 3.0 ± 3.0 J (P < 0.001). (2) AF ablation reduced AF inducibility from 95.4% before the procedure to 56.3% after the procedure (P < 0.001), and the iPCL from 194.8 ± 32.6 to 160.9 ± 26.2 ms (P < 0.001). (3) In patients who underwent a greater number of ablation lines, the post‐RFCA A‐DFT (P < 0.001) was lower, and %ΔA‐DFT (P = 0.003) and proportion of atrial tachycardia (P = 0.022) were higher than those with a lower number of ablation lines. Conclusion: AF ablation significantly reduced A‐DFT, AF inducibility, and iPCL, and the degree of their reduction was related to the number of ablation lines. (PACE 2012;35:1428–1435)     

The Effect of Biphasic Waveform Tilt in Transvenous Atrial Defibrillation

Atrial defibrillation can be accomplished using low energy shocks and transvenous catheters. The biphasic waveform tilt required to achieve optimal atrial defibrillation thresholds (ADFTs) is, however, not known. The effect of single capacitor biphasic waveform tilt modification on ADFT was assessed in 20 patients. Following AF induction the defibrillation pulses were delivered between the catheters positioned in the coronary sinus and the right atrium.
The single capacitor biphasic waveform shocks, delivered over the same pathways, consisted of 65% tilt (65/65 biphasic waveform) to produce an overall tilt of 88%, or 50% tilt (50/50 biphasic waveform) to produce an overall tilt of 75%. Although 65/65 biphasic waveform delivers more energy, the shorter duration 50/50 biphasic waveform reduced stored energy ADFT 21%, from 1.34 ± 0.82 J with 65/65 biphasic to 2.06 ± 0.81 J. These differences were not statistically significant. Nine patients had lower ADFT with 50/50 biphasic waveform while five patients had lower ADFT with 65/65 biphasic waveform. Equivalent reduction in ADFT was seen in the remaining six patients. The ADFT was 0.83 ± 0.65 J when both tilts were considered. In conclusion, biphasic waveform tilt modification may affect the ADFT in an individual patient. The optimal biphasic waveform for ADFT is not known.     

Rapid Atrial Pacing Does Not Decrease the Atrial Defibrillation Threshold

The aim of the study was to evaluate the effect of preshock atrial pacing on the atrial defibrillation threshold (DFT) during internal cardioversion of AF. The implantable atrial defibrillator has been added to the therapeutic options for patients with recurrent episodes of persistent AF. Although the device is efficient in restoring sinus rhythm, patient discomfort is a limitation. Methods that lower the ADFT are needed. Eleven patients with AF underwent internal cardioversion. In a randomized, crossover design, ADFT testing was performed, applying a step-up protocol starting at 100 V. Rapid atrial pacing was performed with a right atrial catheter for 20 seconds at 90% of the average cycle length of the fibrillatory waves and was immediately followed by a biphasic defibrillation shock. At each energy level, pacing + shock was compared to shock only, until the level at which sinus rhythm was restored by both modes. The step-up protocol was thereafter repeated using the inverse sequence of the two modes. A total of 19 ADFTs were obtained. For 10 the ADFT was lower with pacing + shock, in 4 equal and in 5 higher, than with shock only. The ADFT (mean ± SD) with pacing + shock was   260 ± 84   V   (3.4 ± 2.9 J)   and did not differ from shock only:   268 ± 85   V   (3.8 ± 3.0 J) (P > 0.05)   . The coefficient of variation and the coefficient of reproducibility for pacing + shock was 16% and 60 V, respectively, and for shock only 17% and 61 V. Rapid atrial pacing did not influence the internal ADFT in AF. The randomized, crossover protocol used was reproducible between different modes, and seems useful when testing the impact of different interventions on the ADFT. (PACE 2003; 26[Pt. I]:1461–1466)     

The Effects of Atrial Electrical Remodeling on Atrial Defibrillation Thresholds

EVERETT, T.H. et al. : The Effects of Atrial Electrical Remodeling on Atrial Defibrillation Thresholds. Electrical remodeling of atrial fibrillation may account for the increase in atrial defibrillation thresholds over time. The aim of this study was to examine the time course of electrical remodeling and the benefit of early defibrillation on the defibrillation threshold. Twenty‐six mongrel dogs weighing 27.6 ± 3.3 kg were induced into AF by repeated high output burst atrial pacing. Eight dogs were paced for multiple time periods of 5, 20, 40, and 60 minutes. Five dogs each had burst pacing for 4 hours and 8 hours, and eight dogs were paced at a high rate (640 beats/min ) for 48 hours. Biphasic atrial defibrillation shocks with a pulse width of 3/3 ms synchronized to the left apical electrogram were delivered to coil electrode catheters positioned in the lateral left and right atria. Defibrillation voltage was increased from 50 V in 20‐ to 30‐V steps until defibrillation was successful. As the pacing period increased, a decrease in atrial fibrillation cycle lengths and atrial effective refractory period was not observed before 8 hours. Similarly, the defibrillation threshold did not change significantly until the 8‐hour pacing period was reached. The defibrillation thresholds were 69 ± 28 V for 5 minutes, 64 ± 20 V for 20 minutes , 99 ± 85 V for 40 minutes , 78 ± 51 V for 60 minutes , 78 ± 38 V for 4 hours , 124 ± 33 V for 8 hours , and 133 ± 32 V for 48 hours (mean ± SD ) (P < 0.05 ). Atrial electrical remodeling in a rapid atrial pacing canine model is not observed until after 4 hours of burst atrail pacing. The atrial defibrillation threshold increases with increasing duration of burst atrial pacing, and follows a similar time course to other parameters of electrical remodeling.     

Ventricular and Atrial Defibrillation Using New Transvenous Tripolar and Bipolar Leads with 5 French Electrodes and 8 French Subcutaneous Catheters

This study evaluated the use of new small fransvenous atrial and ventricular leads for converting atrial fibrillation (AF) and ventricular fibrillation (VF) in 10 adult male mongrel dogs. Five dogs (group A) received a right atrial "J" (AJ) and right ventricular (RV) active fixation tripolar lead, each consisting of a platinized platinum pacing tip, anode band, and braided defibrillalion electrode. The remaining five dogs (group B) received one bipolar R V lead and one tripolar AJ lead. The RV leads were implanted in the right ventricular upex (RVA) and the AJ leads were placed in the atrial appendage. Additionally all dogs received two 8 French subcutaneous defibrillulion catheters in the fifth and seventh intercostal spaces. Twenty asymmetric biphasic shocks consisting of five randomized voltage levels were used to convert VF in groups A and B. The bipolar RV lead (group B) had a significantly higher probability of success in converting VF than the tripolar RV lend (group A). In group A defibrillation thresholds for converting AF were obtained using two electrode configurations. No significant difference was observed between the two electrode configurations used to convert AF. Pacing and sensing thresholds were satisfactory for bipolar and tripolar lead configuration.     

Heart Weight Affects Spontaneous Defibrillation But Not Ventricular Fibrillation Threshold

Among the factors involved in the induction, generalization, and reversion of cardiac fibrillation, the amount of tissue is a determinant factor. One question is whether an increase in myocardial mass would or would not require the same electrical threshold. Accordingly, one objective was to determine if ventricular weight (VW) has any effect on the fibrillation thresholds (FTs). A second objective was to find a possible relationship between spontaneous defibrillation (SPDE) and heart weight. Fifty mongrel dogs of both sexes were used, of which 26 were 2- to 10-week-old puppies. The rest were adult animals of undetermined age. Fibrillation was induced with two types of stimuli directly applied to the heart. The stimuli were a train of rectangular pulses (TP) not synchronized with the ECG, and single pulses (SP) synchronized with and delayed from the R wave. TP type was used in one group with paddle electrodes; and the TP and SP types were used in a second group with hook electrodes. For both types, stimulation started at a low current and was increased until fibrillation was triggered. Once defibrillated, either spontaneously or by electrical shock, the procedure was repeated. Correlation coefficients between FT and VW were low (< 0.4), and scaling of the thresholds to VW resulted in hyperbolic relationship, for all cases, thus suggesting independence of the two parameters. SPDE fell sharply with weight. For values higher than 12 grams it was essentially nonexistent. VW does not have any effect on the FT but it dramatically influences the capacity of the myocardium to revert the arrhythmia by itself.     

Effect of Increased Parasympathetic and Sympathetic Tone on Internal Atrial Defibrillation Thresholds in Humans

Although changes in autonomic tone affect ventricular defibrillation, little is known about the effect of increased parasympathetic or sympathetic tone on the atrial defbrillation threshold. Methods: To evaluate the effect of reflexly increased parasympathetic and increase α- and β-adrenergic tone on the atrial defibrillation threshold (ADFT), atrial fibrillation was induced in 14 patients. ADFTs, right atrial refractory period (RARP), and monophasic action potential duration (MAPD) were determined before and after autonomic intervention. ADFTs were determined with a step-up protocol using 3/3-ms biphasic shocks delivered through decapolar catheters in the right atrial appendage and coronary sinus. Two groups were studied. Group I (N = 8) had ADFTs determined at baseline, after receiving phenylephrine (PE), and with PE plus atropine (A). Group 2 (N = 6) had ADFTs determined at baseline and after receiving isoproterenol (ISO). Results: Group I: PE significantly increased sinus cycle length (SR-CL) compared to baseline (742 ± 123 to 922 ± 233 ms) without significantly changing RARP, MAPD, or ADFT (2.3 ± 1.3 J vs 2.3 ± 0.8 J). With PE + A, SR-CL significantly decreased (529 ± 100 ms vs 742 ± 123 ms) and MAPD shortened (231 ± 41 ms vs 279 ± 49 ms) without altering RARP or ADFT (1.94 ± 0.9 J vs 2.25 ± 1.25 J). Group 2: ISO decreased SR-CL (486 ± 77 ms vs 755 ± 184 ms) and MAPD (169 ± 37 ms vs 226 + 58 ms) but not RARP or ADFT (2.25 ± 1.21 J vs 2.33 ± 1.75 J). Conclusions: Increasing parasympathetic, α-, or β-adrenergic tone does not affect the ADFT despite causing significant electrophysiological changes in the atria.     

The Effects of Reverse Atrial Electrical Remodeling on Atrial Defibrillation Thresholds

MANGRUM, J.M., et al. : The Effects of Reverse Atrial Electrical Remodeling on Atrial Defibrillation Thresholds. The implantable atrial defibrillator is a developing therapeutic option for paroxysmal atrial fibrillation, but shock related discomfort continues to be a limiting factor. To further characterize successful defibrillation, the relationship between reverse atrial electrical remodeling and internal atrial defibrillation thresholds in canines with chronic atrial fibrillation was examined. Testing was performed in 21 dogs. Chronic atrial fibrillation was induced in eight dogs by creating moderate mitral regurgitation and rapidly pacing the right atrium for ≥ 6 weeks. The atrial fibrillation cycle length, atrial effective refractory period, refractory period dispersion, and internal atrial defibrillation thresholds were determined after establishment of chronic atrial fibrillation after 4 hours of sinus rhythm postcardioversion and 7 days of sinus rhythm postcardioversion. These measurements were then compared to a normal population of 13 dogs. The atrial defibrillation thresholds were 6.6 J (1.9–10.1 J) initially, 2.9 J (1.5–3.7 J) after 4 hours of sinus rhythm, and 0.9 J (0.4 – 1.3 J) after 7 days of sinus rhythm (  P = 0.04  ). This decrease was associated inversely with the atrial effective refractory period (  P < 0.03  ), and atrial fibrillation cycle length (  P < 0.05  ), and with a decrease in atrial refractory period dispersion after 7 days of sinus rhythm (  P = 0.04  ). These electrophysiological measurements reached normal population levels by 7 days. Atrial defibrillation thresholds decrease as atrial reverse electrical remodeling occurs and this reduction corresponds to increased atrial fibrillation cycle length, increased atrial refractoriness, and decreased refractory period dispersion.     

Effects of Transcatheter Cardioversion on Chronic Lone Atrial Fibrillation

The effectiveness and safety of internal transcatheter Cardioversion on chronic lone atrial fibrillation were examined in ten patients resistant to external electrical (400 joules) and pharmacological Cardioversion. Transcatheter Cardioversion was performed by pulling back the atrioventricular junction catheter just inferior to the site of the His-bundle recording and delivering the shock between a proximal electrode (cathode) and backplate (anode). Transcatheter Cardioversion restored sinus rhythm in all of the ten patients. The only complication observed was transient atrioventricular block after the shock and this was treated by temporary pacing. However, atrial fibrillation recurred in five patients at 30, 27, 52, 1, and 6 days, respectively. A second attempt at transcatheter Cardioversion was performed in those patients and was successful in three patients. During a follow-up period ranging from 12 to 22 months, eight patients continued in sinus rhythm. Thus, transcatheter Cardioversion is considered effective and safe in selected patients with chronic lone atrial fibrillation in whom external Cardioversion was unsuccessful.     

Transvenous Catheter Cryoablation for Treatment of Atrial Fibrillation:

Pulmonary vein (PV) isolation using radiofrequency (RF) ablation can induce PV stenosis. Cryoablation may offer a safer alternative energy source for PV isolation. PV isolation with cryoablation was attempted in 31 patients with paroxysmal atrial fibrillation (AF). Event monitors were used to measure the AF episode burden. Serial spiral CT scans were obtained to monitor PV stenosis pre- and postcryoablation. Cryoablation was immediately successful for PV isolation in 29 of 31 patients (94%), with 5.9 ± 1.2 months of follow-up. Additional RF ablation was performed for AF recurrences in seven patients. The remaining 22 patients with a single cryoablation procedure demonstrated a time-dependent, long-term reduction in the frequency of AF episodes. At 6 months of follow-up, 18 of 22 of cryo-treated only patients (82%) were free of symptomatic AF episodes, and antiarrhythmic drugs were discontinued in 12 of 22 patients. Serial spiral CT scans demonstrated no change in the cryo-treated PV ostial diameter. PV cryoablation was effective to control paroxysmal AF in most patients. Early recurrences of AF postcryoablation were common, though tended to resolve within 6 months postablation, consistent with a process of reverse atrial remodeling. Cryoablation of the PVs did not cause PV stenosis or other serious adverse events.     

Low Energy Internal Atrial Cardioversion in Atrial Fibrillation Lasting More Than a Year

The aim of this study was to evaluate the efficacy of low energy internal atrial cardioversion in restoring sinus rhythm (SR) in patients with chronic atrial fibrillation (AF) persisting > 1 year. Fifteen patients with chronic AF lasting > 1 year (from 13–48 months, mean 24 ± 13 months) were studied. R wave synchronized 3/3 ms biphasic shocks were delivered between right atrial and coronary sinus (left pulmonary artery in five patients) electrodes. Sedatives or anesthetics were administered only at the patient's request. Results: Stable SR was restored in 14 (93%)of 15 patients after shocks with a mean leading edge voltage of 377 ± 77 V (range 260–500) and a mean delivered energy of 7.3 ± 3.4 J (range 2.6–12.9). The procedure was performed without anesthesia in 6 (40%) patients. All successfully cardioverted patients were treated with flecainide, sotalol, or amiodarone. During a follow up of 7.7 ± 7.9 months (range 1–24) AF recurred in five (36%) patients. Three of five AF recurrences occurred within 3 days after conversion to SR. Conclusion: Internal low energy atrial cardioversion is highly effective in restoring SR even in patients with AF lasting > 1 year. The long-term results from the standpoint of freedom from AF recurrences, are satisfactory, although additional antiarrhythmic treatment is required, particularly in the first days after conversion.     

Internal Atrial Defibrillation: Effect on Sinus and Atrioventricular Nodal Function and Implanted Cardiac Pacemakers

Internal atrial defibrillation (IAD) has been extensively evaluated for clinical efficacy but the need for concomitant demand pacing and the effect of IAD shocks on pacemaker function is not well studied. We prospectively evaluated: (l) the incidence of bradycardia as a result of IAD shocks; and (2) effect of these shocks on functioning of implanted cardiac pacemakers. Consecutive consenting patients with atrial fibrillation (AF) requiring cardioversion or undergoing electrophysiologi-col study were selected for IAD. IAD shocks were delivered using the right ventricle to right atrium (RV-RA), right ventricle to superior vena cava (RV-SVC), right atrium to axillary patch (RA-AX), and right atrium to left pulmonary artery or coronary sinus (RA-LPA/CS) lead configurations. Mean RR interval before and after the shocks and the time interval from shock delivery to first QRS complex were analyzed for unsuccessful and successful shocks. Pacing and sensing function was analyzed in patients with previously implanted pacemakers. Twenty-five patients, 18 men, mean age 67.9 ± 10 years were included in the study. A total of 305 shocks (264 unsuccessful, 41 successful) were analyzed. For unsuccessful shocks the mean post-IAD shock RR interval (795 ± 205 ms) and the time to first post-IAD shock QRS complex (970 ± 438 ms) were both significantly greater than the pre-IAD shock RR interval (685 ±131 ms, P < 0.001). The increase in post-IAD shock RB interval and time to first post-IAD shock QRS complex was seen with all four lead configurations used. With successful shocks the mean post-IAD shock sinus cycle length (1.105 ± 450 ms) and time to first post-IAD shock QRS complex (1,126 ± 443 ms) were both also significantly greater than the pre-IAD shock RR interval (766 ±172 ms). Nine patients (36%) had episodes of significant bradycardia after shock delivery. Shocks of up to 20 J using the RA-LPA/CS lead configuration did not affect pacemaker function. IAD can result in transient bradycardia related to sinus and atrioventricular nodal effects requiring backup ventricular pacing. Shocks can be safely delivered using RA-LPA or RA-CS lead configurations in patients with implanted bipolar cardiac pacemakers.     

Preimplant Atrial Defibrillation Testing with a Temporary Catheter in Sheep

Prior to implantation of an atrial defibrillator, its effectiveness should be tested in each patient. A new catheter design for temporary use with electrodes for atrial defibrillation, electrogram sensing, and pacing was tested in this study. Atrial defibrillation thresholds defined using this temporary catheter were compared to the ones defined by catheters intended for chronic use with an implantable atrial defibrillator. Atrial defibrillation threshold was determined in six sheep using both types of catheters. Each animal was subjected to studies on 2 consecutive days. On the first day, shocks were applied between two of the temporary catheters. On the following day, permanent leads were inserted and atrial defibrillation threshold was redetermined. In both cases, defibrillation electrodes were positioned in the same heart location with one electrode in the distal coronary sinus and the second electrode in the right atrium. Atrial defibrillation threshold was obtained using 10 V increments or decrements to determine the lowest shock intensity needed to defibrillate the atria. Threshold was defined as the shock intensity at which 20 shock percent success was at or between 15 % and 85%. Statistical analysis showed no significant difference (P < 0.05) between atrial defibrillation threshold energy (0.53 J vs 0.55 J), voltage (122 V vs 120 V) or current (2.2 A vs 2.6 A) measured with the temporary catheters and the permanent leads, respectively. These data indicate that temporary catheters can be used for efficacy testing prior to implant of an atrial defibrillator, and that they predict atrial defibrillation threshold adequately for chronic leads.     

Pacemaker Failure Following External Defibrillation

An 81-year-old female with the sick sinus syndrome had a permanent pacemaker implanted. She subsequently developed ventricular fibrillation and was successfully defibrillated. However, the defibrillation paddle was placed on the pulse generator which led to a complete loss of function of the pulse generator. External defibrillation can produce varying degrees of damage to the implanted pulse generator. The resultant abnormalities are discussed and recommended defibrillation procedures are also outlined in this report.     

Pain Threshold for Low Energy Intracardiac Cardioversion of Atrial Fibrillation with Low or No Sedation

Recent studies have shown that internal cardioversion of atrial fibrillation is safe and effective. In this randomized prospective study, we have tried to evaluate the influence of different waveforms on the perception of pain during internal cardioversion in patients with chronic atrial fibrillation. Methods: Internal cardioversion was performed with minimal or no sedation in 31 consecutive patients, R wave triggered, biphasic shocks of 6 ms/6 ms or 3 ms/3 ms duration (randomly selected) and approximately 65% tilt were used starting with a 50-V test shock. The shock intensity was increased in 40-V steps up to a maximum voltage of 520 V. Shocks were applied via two custom-made catheters (Elecath, Rahway, NJ). In 16 patients (3 females, age 61 ± 11 years, left atrium diameter 58 ± 5 mm, duration of atrial fibrillation 4 ± 4 months), 6/6 waveforms were used, and in 15 patients (1 female, age 62 ± 5 years, left atrium diameter 59 ± 4 mm, duration of atrial fibrillation 5 ± 2 months), 3/3 waveforms were used. After cardioversion, each patient was asked to quantify their pain on a scale from 0–10 (0 = no pain, 10 = intolerable). Fourteen of the 15 patients in the 3/3 ms and 15 of the 16 patients in the 6/6 ms group were successfully cardioverted. Patients from the 6/6 waveform group were cardioverted with a lower mean voltage of 254/92 versus 355/127 V (P < 0.02), at lower pain score 1.8 ± 1.3 versus 4.2 ± 2.2 (P < 0.05) with equivalent energy (6.8 ± 2.8 versus 6.2 ± 1.5 J, n.s.) and required lower doses of midazolam of 2.2 ± 1.9 versus 4.0 ± 1.8 mg IV (P < 0.02). The waveform used in internal cardioversion seems to have a major impact on the patients’ perception of pain. These results imply that energy determines the success of a shock, but voltage determines the pain perceived by the patient. The use of waveforms that deliver greater energy at lower peak voltages offers the possibility of internal cardioversion with less sedation and greater patient tolerance.